Isansys Lifecare, a digital healthcare company which has created and developed the world’s most advanced real-time patient data collection and analysis platform, has been granted a US patent covering a key feature of its Lifetouch cardiac sensor. The US patent adds to a suite of already issued European patents for the wireless smart patch device.
The Lifetouch is a vital component of the Patient Status Engine (PSE), a Class 11 (CE and FDA) continuous multiple vital sign patient monitoring platform that automatically and continuously collects and analyses patients’ vital signs to provide real-time information and predictive insights for clinicians, nurses and for patients themselves.
Keith Errey, CEO of Isansys, said: “The granting of this patent in the US for the Lifetouch is an important step in reconfiguring the idea of a medical device from product to AI augmented platform. The patented technology enhances the Patient Status Engine creating an even smarter platform that can dynamically reprogram the Lifetouch according to what it is detecting in an individual. This means healthcare providers receive more specific, higher resolution data leading to faster diagnostics and better care for the patient.”
The granting of this patent reinforces Isansys position as the market-leader in new generation wireless patient monitoring technology and patient digitisation systems and services.